This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Female Health Company To Present At 7th Annual Singular Research Conference

CHICAGO, Oct. 30, 2012 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO), which manufactures and markets the FC2 Female Condom, today announced that it will be presenting at the Singular Research Seventh Annual "Best of the Uncovereds" Conference on Thursday, November 1, 2012, in Los Angeles, California.

(Logo: http://photos.prnewswire.com/prnh/20120712/MM39764LOGO)

The Company's Chief Executive Officer, O.B. Parrish, and Chief Financial Officer, Donna Felch, are scheduled to present at 1:30 p.m. Pacific Time ( 4:30 p.m. Eastern Time). A live webcast of this presentation will be available on the Internet at http://www.singularresearch.com.

During the remainder of the day, management will meet with investors during a series of one-on-one breakout meetings. Interested parties should contact Bill Jones at Singular (267-987-2082) to schedule a meeting. The conference is being held at the Luxe Sunset Boulevard Hotel in Los Angeles.

About Singular ResearchSingular Research aims to be the most trusted supplier of independent single-source research on small-to-micro cap companies for small-to-medium-sized money managers. Singular will provide quarterly updates for 30 to 60 companies and make recommendations. Singular's goal is to provide initiation reports and quarterly updates for approximately 50 micro-to-small-cap companies. Singular's independent analysts have no financial interest in the stocks they cover. Analysts are compensated based on the accuracy of their research calls, not through trading commissions or potential deal flow. Singular's coverage list performance since inception in August 2004 is a positive 153.59% through December 2011, compared with a positive 13.88% for the S&P 500. For more information about Singular Research, visit http://www.singular-research.com.  For more information about the conference, please contact:

Robert Maltbie, CFA Singular Research818-222-6915 robert@singularresearch.com

About The Female Health Company The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom® (FC2), which is available in the U.S. and approximately 138 other countries. The Company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued in the U.S., the European Union, Canada, Australia, South Africa, Japan, The People's Republic of China, Spain, Mexico, Greece, Turkey and by the African Regional Intellectual Property Organization (ARIPO), which includes Botswana, The Gambia, Ghana, Kenya, Lesotho, Malawi, Mozambique, Namibia, Sierra Leone, Somalia, Sudan, Swaziland, Uganda, United Republic of Tanzania, Zambia and Zimbabwe.  FC2 patent applications are pending in various countries.  The FC2 Female Condom® is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies. 

"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:

The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings.  Actual events affecting the Company and the impact of such events on the Company's operations may vary from this currently anticipated.

For more information about the Female Health Company visit the Company's website at http://www.femalehealth.com and http://www.femalecondom.org. If you would like to be added to the Company's e-mail alert list, please send an e-mail to FHCInvestor@femalehealthcompany.com.

SOURCE The Female Health Company

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,127.29 +47.15 0.26%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs